scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0041-1345(00)02113-8 |
P698 | PubMed publication ID | 11266929 |
P2093 | author name string | A W Thomson | |
P P Luke | |||
P2860 | cites work | Dendritic cells and the control of immunity | Q27860918 |
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 | ||
Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway | Q33811694 | ||
Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule | Q34298838 | ||
Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes | Q34396514 | ||
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates | Q34433847 | ||
Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients | Q35160185 | ||
In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines | Q36375434 | ||
Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion | Q42941965 | ||
Feasibility of CTLA4Ig gene delivery and expression in vivo using retrovirally transduced myeloid dendritic cells that induce alloantigen-specific T cell anergy in vitro | Q44321933 | ||
Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients | Q45862110 | ||
OX-40: life beyond the effector T cell stage. | Q52036718 | ||
Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies | Q56909256 | ||
Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance | Q57202280 | ||
LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response | Q73644490 | ||
Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival | Q74015557 | ||
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates | Q77890140 | ||
P433 | issue | 1-2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 507-508 | |
P577 | publication date | 2001-02-01 | |
P1433 | published in | Transplantation Proceedings | Q7834825 |
P1476 | title | Blockade of costimulatory molecules on dendritic cells: implications for tolerance induction | |
P478 | volume | 33 |
Q41882308 | Interleukin-10 modified dendritic cells induce allo-hyporesponsiveness and prolong small intestine allograft survival | cites work | P2860 |
Search more.